- Sentia Medical Sciences Inc. Awarded Approximately $1.8 million Phase II Small Business Innovation Research (SBIR) Grant to Develop Astressins for the Treatment of Irritable Bowel Syndrome (IBS)
- HIV Cure Program Patent Granted To American Gene Technologies
- Seelos Therapeutics Reports Q1 2019 Pipeline Update
- Jerome Zeldis, M.D., Ph.D, Former Chief Medical Officer of Celgene, to Join BioSig Board of Directors - Corrected Version
- IMARC Research Focuses On Strategic Growth in 2020
- IMARC Research Focuses On Strategic Growth in 2020
- Axsome Therapeutics To Present Data From ASCEND Phase 2 Trial Of AXS-05 In Major Depressive Disorder At The 2019 American Society For Clinical Psychopharmacology Annual Meeting
- RedHill Biopharma Expands Commercial Management Team Ahead of Planned Talicia® Launch
- Dr. Jerome Zeldis, M.D., Ph.D, Former Chief Medical Officer of Celgene, to Join BioSig Board of Directors
- Intrommune Therapeutics Receives Best Private Company Presentation Award at BioNJ’s 9th Annual BioPartnering Conference
